ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-106621

ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of th…

Published Oct 13, 2026 · catalog updated Oct 15, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-106621. EPSS is 0.68%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.68%
Remediation
Advisory link
Affected products
cpe adobe/coldfusion

ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe adobe/coldfusion2023

How to fix CVE-2026-106621

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-106621. EPSS is 0.68%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Compare what you have installed with 2023. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-94: Code Injection. EPSS 0.68%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 13, 2026 · Catalog

    Detected

    ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction.

  2. Oct 14, 2026 · NIST NVD

    Updated

    ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction.

  3. Oct 15, 2026 · NIST NVD

    Updated

    ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction.

Sources

  • CVE.orgVulnerability recordCVE-2026-106621

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-106621

    30-day exploitation probability 0.7%

    first.org
  • NIST NVDVulnerability recordCVE-2026-106621

    ColdFusion is affected by an Improper Control of Generation of Code ('Code Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issu

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.